Bayesian Capital Management’s XP XP Stock Holding History

Bayesian Capital Management’s Portfolio XP Stock Details XP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33,700	Closed	-$463K	–	911
2025 Q1	$463K	Buy	+33,700	New	+$464K	0.08%	311
2024 Q4	–	Sell	-106,600	Closed	-$1.91M	–	1042
2024 Q3	$1.91M	Buy	106,600 +48,000	+82%	+$875K	0.22%	132
2024 Q2	$1.03M	Sell	58,600 -20,300	-26%	-$419K	0.12%	226
2024 Q1	$2.02M	Buy	+78,900	New	+$1.98M	0.19%	153
2023 Q4	–	Sell	-28,379	Closed	-$654K	–	1069
2023 Q3	$654K	Sell	28,379 -105,800	-79%	-$2.65M	0.07%	308
2023 Q2	$3.15M	Buy	+134,179	New	+$2.28M	0.34%	61
2022 Q4	–	Sell	-38,500	Closed	-$732K	–	1062
2022 Q3	$732K	Buy	38,500 +26,000	+208%	+$516K	0.15%	189
2022 Q2	$224K	Buy	+12,500	New	+$288K	0.04%	587
2022 Q1	–	Sell	-20,648	Closed	-$593K	–	946
2021 Q4	$593K	Buy	+20,648	New	+$672K	0.19%	158
2021 Q1	–	Sell	-23,400	Closed	-$928K	–	721
2020 Q4	$928K	Buy	+23,400	New	+$956K	0.24%	114
2020 Q2	–	Sell	-13,500	Closed	-$260K	–	831
2020 Q1	$260K	Buy	+13,500	New	+$456K	0.06%	509

Other funds holding XP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

ACGDR

Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bayesian Capital Management's XP Position: Q2 2025 in Review

Bayesian Capital Management sold out of XP (XP) in Q2 2025, closing a stake of 33,700 shares — an estimated $463K sold.

Bayesian Capital Management first reported a position in XP in Q1 2020 and held it in 11 quarters. The position peaked at $3.15M in Q2 2023. 313 funds tracked by Wall St. Rank hold XP as of Q2 2025.

Bayesian Capital Management reported no remaining XP position as of Q2 2025 after selling out during the quarter.
Bayesian Capital Management sold 33,700 XP shares in Q2 2025, an estimated $463K.
Bayesian Capital Management first reported a position in XP in Q1 2020 and held it in 11 quarters.
Bayesian Capital Management's XP position peaked at $3.15M in Q2 2023.
313 funds tracked by Wall St. Rank held XP as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.